AR028281A1 - Derivados de 2-(arilalquilamino) pirimidona y derivados de 2-(heteroaroarilalquilamino) pirimidona - Google Patents

Derivados de 2-(arilalquilamino) pirimidona y derivados de 2-(heteroaroarilalquilamino) pirimidona

Info

Publication number
AR028281A1
AR028281A1 ARP010101373A ARP010101373A AR028281A1 AR 028281 A1 AR028281 A1 AR 028281A1 AR P010101373 A ARP010101373 A AR P010101373A AR P010101373 A ARP010101373 A AR P010101373A AR 028281 A1 AR028281 A1 AR 028281A1
Authority
AR
Argentina
Prior art keywords
pirimidona
derivatives
heteroaroarilalquilamino
arilalquilamino
Prior art date
Application number
ARP010101373A
Other languages
English (en)
Original Assignee
Sanofi Synthelabo
Mitsubishi Tokyo Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2000081938A external-priority patent/JP2001270884A/ja
Priority claimed from EP00400806A external-priority patent/EP1136491A1/en
Priority claimed from EP00400805A external-priority patent/EP1136099A1/en
Priority claimed from EP00400804A external-priority patent/EP1136484A1/en
Application filed by Sanofi Synthelabo, Mitsubishi Tokyo Pharm Inc filed Critical Sanofi Synthelabo
Publication of AR028281A1 publication Critical patent/AR028281A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ARP010101373A 2000-03-23 2001-03-23 Derivados de 2-(arilalquilamino) pirimidona y derivados de 2-(heteroaroarilalquilamino) pirimidona AR028281A1 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2000081938A JP2001270884A (ja) 2000-03-23 2000-03-23 ピリミドン誘導体
EP00400806A EP1136491A1 (en) 2000-03-23 2000-03-23 2-[(Heteroaryl)alkylamino]pyrimidone derivatives
EP00400805A EP1136099A1 (en) 2000-03-23 2000-03-23 2-(Indolylalkylamino)pyrimidone derivatives as GSK3beta inhibitors
EP00400804A EP1136484A1 (en) 2000-03-23 2000-03-23 2-(Arylalkylamino)pyrimidone derivatives

Publications (1)

Publication Number Publication Date
AR028281A1 true AR028281A1 (es) 2003-04-30

Family

ID=27440051

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP010101373A AR028281A1 (es) 2000-03-23 2001-03-23 Derivados de 2-(arilalquilamino) pirimidona y derivados de 2-(heteroaroarilalquilamino) pirimidona

Country Status (3)

Country Link
AR (1) AR028281A1 (es)
AU (1) AU2001248365A1 (es)
WO (1) WO2001070727A1 (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0300927A2 (hu) 2000-04-26 2003-07-28 Eisai Co., Ltd. Új pirimidinszármazékok és ezeket tartalmazó defekációt elősegítő gyógyszerkészítmények
TWI335221B (en) * 2001-09-27 2011-01-01 Alcon Inc Inhibtors of glycogen synthase kinase-3 (gsk-3) for treating glaucoma
TWI301834B (en) * 2001-10-22 2008-10-11 Eisai R&D Man Co Ltd Pyrimidone compound and pharmaceutical composition including the same
TWI330183B (es) 2001-10-22 2010-09-11 Eisai R&D Man Co Ltd
AU2003220026A1 (en) * 2002-03-01 2003-09-16 Chiron Corporation Methods and compositions for the treatment of ischemia
EP1616568A3 (en) * 2002-04-30 2006-06-21 Alcon, Inc GSK-3 inhibitors and CDK inhibitors as anti-glaucoma agents
US7351407B2 (en) 2002-04-30 2008-04-01 Alcon, Inc. Agents which regulate, inhibit, or modulate the activity and/or expression of connective tissue growth factor (CTGF) as a unique means to both lower intraocular pressure and treat glaucomatous retinopathies/optic neuropathies
EP1556355A1 (en) 2002-10-21 2005-07-27 Chiron Corporation Inhibitors of glycogen synthase kinase 3
JP2007520558A (ja) * 2004-02-04 2007-07-26 スミスクライン・ビーチャム・コーポレイション キナーゼ阻害剤として有用なピリミジノン化合物
JP2008535779A (ja) 2005-01-07 2008-09-04 エモリー・ユニバーシテイ Hiv感染治療のためのcxcr4拮抗薬
EP2258359A3 (en) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenesis by muscarinic receptor modulation with sabcomelin
JP2009506069A (ja) 2005-08-26 2009-02-12 ブレインセルス,インコーポレイティド ムスカリン性受容体調節による神経発生
US7985756B2 (en) 2005-10-21 2011-07-26 Braincells Inc. Modulation of neurogenesis by PDE inhibition
WO2007053596A1 (en) 2005-10-31 2007-05-10 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
WO2007134136A2 (en) 2006-05-09 2007-11-22 Braincells, Inc. Neurogenesis by modulating angiotensin
JP2009543802A (ja) * 2006-07-11 2009-12-10 エモリー・ユニバーシテイ 医学的疾患の治療のためのジアジン及びトリアジン構造を含むcxcr4アンタゴニスト
CA2658263A1 (en) 2006-07-18 2008-01-24 University Of Rochester Thiadiazolidinone derivatives
MX2009001913A (es) * 2006-08-23 2009-03-06 Pfizer Prod Inc Compuestos de pirimidona como inhibidores de gsk-3.
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
CL2008003120A1 (es) * 2007-11-01 2009-10-09 Acucela Inc Compuestos derivados de fenilalquil-, fenilalquenil-, fenilalquinil- amina, feniltioalquilamina, fenilaminoalquilamina, fenilalcoxiamina y fenilalquilguanidina; composicion farmaceutica; y uso de los compuestos para tratar un trastorno o enfermedad oftalmologica tal como retinopatia, maculopatia, retinitis pigmentosa, uveitis, entre otras.
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR038955A1 (es) * 1996-12-05 2005-02-02 Amgen Inc Compuestos de pirimidinona y piridona sustituidos y metodos para su uso

Also Published As

Publication number Publication date
WO2001070727A1 (en) 2001-09-27
AU2001248365A1 (en) 2001-10-03

Similar Documents

Publication Publication Date Title
AR028567A1 (es) Nuevos derivados de fenil-propargileter
AR028596A1 (es) Nuevos derivados de fenilglicina
ID30590A (id) Celana sekali pakai jenis-celana pendek
NO20025978D0 (no) Benzotiazol-derivater
MA27126A1 (fr) 3'PROMEDICAMENTS DE 2'-DESOXY- β-L-NUCLEOSIDES
AR028343A1 (es) Derivados de pirrolidina y piperidina
AR027938A1 (es) Compuestos uracilo y utilizacion de los mismos
DE60134338D1 (de) Piperazin-derivate
DK1292604T3 (da) 2-Aminocarbonyl-9H-purinderivater
DE60043343D1 (de) Chromenderivate
DE50112013D1 (de) Deodorantien und antiperspirantien
DK1280809T3 (da) Antitumorecteinascidinderivater
ATE298332T1 (de) Decahydro-isochinolinderivate
DE60032898D1 (de) Arylthiazolidindion- und aryloxazolidinderivate
PT1246817E (pt) Derivados de 4-fenil-1-piperazinilo, -piperidinilo e -tetra-hidropiridilo
PT1322592E (pt) Derivados substituidos de 1-aminobutan-3-ol
AR028607A1 (es) Derivados de 1,4-diazepan-2,5-diona
DE60117096D1 (de) Dihydroindol- und tetrahydrochinolinderivate
DK1246791T3 (da) Aminomethyl-phenyl-cyklohexanonderivater
DE60031450D1 (de) Polymorph v von torasemid
PT1178984E (pt) Derivados de 1-trifluorometil-4-hidroxi-7-piperidinilamimometilcromano
PT1392670E (pt) Derivados substituidos de c-furan-2-il-metilamina e c-tiofen-2-il-metilamina
AR027964A1 (es) Combinacion de fibras y derivados epnxicos termoplasticos
DE60007360T2 (de) Amorphe modifikation von torasemid
NO20023675L (no) Heterocykliske amidderivater

Legal Events

Date Code Title Description
FB Suspension of granting procedure